From Health Affairs Today <[email protected]>
Subject JUST RELEASED: Health Impacts of Early OxyContin Marketing
Date July 19, 2023 8:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Addressing The Mental Health Equity Crisis: Can The Private Sector Lead?
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌


 

View Message in Browser
<[link removed]>


[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

Wednesday, July 19, 2023 | The Latest Research, Commentary, And News
From Health Affairs

Dear John,

Julia Dennett and Gregg Gonsalves today released an ahead-of-print
article
<[link removed]>
examining how OxyContin's marketing practices in 1996 have led to
serious long-term health problems even today.

[link removed]


Early OxyContin Marketing Still Problematic Today

Julia Dennett and Gregg Gonsalves explore the long-term impacts of the
marketing of OxyContin
<[link removed]>,
a prescription opioid analgesic, in 1996 in their newly published Health
Affairs article.

Their study compares outcomes between states with high and low levels of
exposure to early OxyContin marketing both before and after the 2010
reformulation of OxyContin.

Dennett and Gonsalves conclude that "exposure to initial OxyContin
marketing statistically significantly increased fatal synthetic
opioid-related overdose rates; incidence of acute hepatitis A, hepatitis
B, and hepatitis C; and infective endocarditis-related mortality rates
after the 2010 OxyContin reformulation."

These findings suggest that OxyContin marketing in 1996 is related to
adverse long-term health outcomes over twenty-five years later.

Read the Article
<[link removed]>


[link removed]


Health Affairs' Forefront series, "Private Sector Solutions for Health
Equity,"
<[link removed]>
is back!

Supported by CVS Health and featuring health equity experts as they
examine private-sector initiatives and responsibility to advance health
equity, the series includes articles exploring private-sector efforts to
challenge injustices in health care.

In the latest article in the series
<[link removed]>,
Wizdom Powell from Headspace Health asks whether the private sector can
lead the mental health equity crisis.

This series will publish new articles through Friday, July 21.

Read the Article
<[link removed]>


 

[link removed]


Join us for this upcoming virtual event!

July 31: Journal Club: Documenting Latino Representation in the US
Workforce
<[link removed]>

 

[link removed]

<[link removed]>

Addressing The Mental Health Equity Crisis: Can The Private Sector Lead?
<[link removed]>
Wizdom Powell

Insult To The Injured: The Case For Modernizing Vaccine Injury
Compensation
<[link removed]>
Renee Gentry and Richard Hughes

 

[link removed]


 

About Health Affairs

Health Affairs is the leading peer-reviewed journal
<[link removed]> at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org <[link removed]>, Health
Affairs Today <[link removed]>, and Health
Affairs Sunday Update <[link removed]>.  

Project HOPE <[link removed]> is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy <[link removed]>

To unsubscribe from this email, update your email preferences here
<[link removed]>.
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
Screenshot of the email generated on import

Message Analysis